Charter Oak Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Charter Oak Capital Management's LLY Position: Q1 2026 in Review
Charter Oak Capital Management reduced its Eli Lilly (LLY) stake by 0.18% in Q1 2026, selling an estimated $2.03K and leaving 1,095 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #83.
Charter Oak Capital Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.18M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Charter Oak Capital Management held 1,095 shares of Eli Lilly worth $1.01M as of Q1 2026.
- Charter Oak Capital Management sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
- Eli Lilly made up 0.08% of Charter Oak Capital Management's portfolio in Q1 2026, its #83 holding.
- Charter Oak Capital Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- Charter Oak Capital Management's Eli Lilly position peaked at $1.18M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.